{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:36:46Z","timestamp":1769589406633,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T00:00:00Z","timestamp":1572134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012629","name":"the Japan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EPS"},{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.trim.2019.101247","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T02:05:21Z","timestamp":1572141921000},"page":"101247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"57","author":[{"given":"Shosaku","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Tsubokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0005","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1073\/pnas.78.4.2249","article-title":"Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C","volume":"78","author":"Esmon","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2019.101247_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1538-7836.2011.04319.x","article-title":"Thrombomodulin: protectorate god of the vasculature in thrombosis and inflammation","volume":"9","author":"Ito","year":"2011","journal-title":"J. Thromnb. Haemost."},{"issue":"7","key":"10.1016\/j.trim.2019.101247_bb0015","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/j.1460-2075.1987.tb02448.x","article-title":"Strucure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation","volume":"6","author":"Suzuki","year":"1987","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.trim.2019.101247_bb0020","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/S0021-9258(18)83672-9","article-title":"A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation","volume":"264","author":"Suzuki","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.trim.2019.101247_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.trim.2019.101247_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40560-014-0050-7","article-title":"Thrombomodulin\/activated protein C system in septic disseminated intravascular coagulation","volume":"3","author":"Ikezoe","year":"2015","journal-title":"J. Intensive Care"},{"issue":"11","key":"10.1016\/j.trim.2019.101247_bb0035","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2019.101247_bb0040","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1160\/TH09-10-0700","article-title":"Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy","volume":"103","author":"Stoffel","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.trim.2019.101247_bb0045","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood.V97.9.2886","article-title":"Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect","volume":"97","author":"Schmaltz","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.trim.2019.101247_bb0050","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.trim.2019.101247_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1189\/jlb.1111561","article-title":"Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality","volume":"91","author":"Castor","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.trim.2019.101247_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JBM.S93008","article-title":"Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Nomura","year":"2016","journal-title":"J. Blood Med."},{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/bmt.2009.217","article-title":"Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"45","author":"Ikezoe","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2009.242","article-title":"Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin","volume":"45","author":"Sakai","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2019.101247_bb0080","first-page":"1118","article-title":"Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation ?","volume":"105","author":"Nomura","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.trim.2019.101247_bb0085","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1182\/blood.V124.21.5089.5089","article-title":"Recombinant thrombomodulin for the treatment of transplantation- associated coagulopathy after allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Ishii","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trim.2019.101247_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trim.2017.06.004","article-title":"Association between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation","volume":"43\/44","author":"Nomura","year":"2017","journal-title":"Transplant. Immunol."},{"key":"10.1016\/j.trim.2019.101247_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trim.2018.12.001","article-title":"Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation","volume":"53","author":"Nomura","year":"2019","journal-title":"Transplant. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2019.101247_bb0100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2019.101247_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.trim.2019.101247_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2019.101247_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12185-013-1421-x","article-title":"Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses","volume":"98","author":"Maeda","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.trim.2019.101247_bb0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2019.101247_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.tp.0000200312.29965.35","article-title":"Diagnosis of acute graft-versus-host disease","volume":"81","author":"Will","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2019.101247_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2019.101247_bb0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbmt.2009.10.002","article-title":"Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation","volume":"16","author":"Kornblit","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2019.101247_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-010-1033-1","article-title":"High-mobility group box 1 (HMGB1) as a master regulator of innate immunity","volume":"343","author":"Castiglioni","year":"2011","journal-title":"Cell Tissue Res."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419301297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419301297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:12Z","timestamp":1760810352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327419301297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"alternative-id":["S0966327419301297"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2019.101247","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2019.101247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101247"}}